Agenus reported $3.42M in Equity Capital and Reserves for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agenus AGEN:US $ 3.42M 12.3M
Amgen AMGN:US $ 2419M 1503M
AstraZeneca AZN:LN 35932M 408M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Celldex Therapeutics CLDX:US $ 365.09M 33.01M
Chemocentryx CCXI:US $ 236.53M 22.19M
CSL CSL:AU $ 14.03B 5.65B
Dynavax Technologies DVAX:US $ 422.8M 135.32M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Genocea Biosciences GNCA:US $ 12.38M 14.69M
Gilead Sciences GILD:US $ 20215M 288M
Glaxosmithkline GSK:US $ 16374M 193M
GlaxoSmithKline GSK:LN 16374M 193M
Immunogen IMGN:US $ 249.83M 56.64M
Intrexon XON:US $ 55.65M 18.18M
Jiangsu Hengrui Me. 600276:CH CH 36.24B 1.24B
Karyopharm Therapeutics KPTI:US $ -116338000 33.26M
Macrogenics MGNX:US $ 142.48M 35.73M
Merck MRK:GR € 25955M 3036M
Northwest Biotherapeutics NWBO:US -120525000 3.47M
Novartis NOVN:VX SF 62925M 1385M
Novavax NVAX:US $ -416.95M 482.27M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Rigel Pharmaceuticals RIGL:US $ -3.68M 10.48M
Sangamo Biosciences SGMO:US $ 318.28M 16.24M
Veracyte VCYT:US $ 1064.15M 21.04M
YTE INCY:US $ 4085.06M 221.99M